Steve Forte is EVP, CHIEF FINANCIAL OFFICER of Repare Therapeutics Inc.. Currently has a direct ownership of 54,786 shares of RPTX, which is worth approximately $55,333. The most recent transaction as insider was on Mar 12, 2025, when has been sold 6,884 shares (Common Shares) at a price of $1.14 per share, resulting in proceeds of $7,847. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.8K
22.36% 3M change
29.79% 12M change
Total Value Held $55,333

Steve Forte Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 12 2025
SELL
Open market or private sale
$7,847 $1.14 p/Share
6,884 Reduced 11.16%
54,786 Common Shares
Mar 04 2025
BUY
Grant, award, or other acquisition
-
14,000 Added 18.5%
61,670 Common Shares
Apr 01 2024
SELL
Open market or private sale
$3,637 $4.61 p/Share
789 Reduced 1.73%
44,775 Common Shares
Mar 28 2024
SELL
Open market or private sale
$3,811 $4.62 p/Share
825 Reduced 1.78%
45,564 Common Shares
Mar 27 2024
SELL
Open market or private sale
$3,811 $4.62 p/Share
825 Reduced 1.92%
42,212 Common Shares
Mar 26 2024
SELL
Open market or private sale
$3,794 $4.6 p/Share
825 Reduced 1.88%
43,037 Common Shares
Mar 25 2024
SELL
Open market or private sale
$3,951 $4.79 p/Share
825 Reduced 1.85%
43,862 Common Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
14,000 Added 23.86%
44,687 Common Shares
Jan 30 2023
BUY
Grant, award, or other acquisition
-
24,530 Added 44.42%
30,687 Common Shares
SF

Steve Forte

EVP, CHIEF FINANCIAL OFFICER
St Laurent, A8

Track Institutional and Insider Activities on RPTX

Follow Repare Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

News

Receive news related to Repare Therapeutics Inc.

Track Activities on RPTX